Since this "lack of vacuum vial" is an experiment in progress, here's a more practical contribution. A quick protocol to measure what lack of vacuum / oxidation does to rHGH, that is, cause post reconstitution instability that needs to be evaluated over the course of several days post reconstitution. Two studies attached that clearly demonstrate how this happens to rHGH, and why pharma uses an inert gas to prevent lyophilized rHGH from being exposed to oxygen.
In plain english, if your rHGH vial lacks vacuum, the air that's now in the vial (20% oxygen), oxidizes the methionine in the rHGH, making it less durable and degrade (unfold and aggregate) faster once reconstituted than if it was vacuum sealed.
If you reconstitute and immediately measure purity, there probably won't be much of difference noticed.
View attachment 347683View attachment 347684